Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases (Document, Website)WHO
19 March 2020
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China.
APHL Webinar: Navigating and Mitigating Laboratory Risks during COVID-19 (Webinar)ABSA/APHL
22 October 2020
PREVIOUSLY RECORDED WEBINAR
This webinar will provide attendees with knowledge on how to safely and securely handle respiratory and other specimens from persons under investigation (PUIs). Speakers will present on the biological risk assessment process to mitigate risks in the laboratory and reduce the likelihood of a laboratory acquired infection. Participants will also hear from both public health and clinical laboratories on their lessons learned. This webinar will be recorded and made available for those unable to listen live
APHL Webinar: Coronavirus Disease (COVID-19): Laboratory Risk Assessments and Lessons Learned (Website, Webinar)APHL
A free webinar was hosted by the Association of Public Health Laboratories on 3/12/2020.
Knowledge on how to safely and securely handle respiratory and other specimens from persons under investigation (PUIs) and the biological risk assessment process to mitigate risks in the laboratory and reduce the likelihood of a laboratory acquired infection. Participants will also heard from both public health and clinical laboratories on their lessons learned. This webinar has been recorded. You must register with APHL to view the free webinar.
COVID-19 and Beyond: Safety and Design Considerations for the Development of a Mobile Biocontainment Laboratory (Website, Publication)Applied Biosafety: Journal of ABSA International
7 August 2020
M Linster, B Ng, V Vijayan
